PubMed:36939991
Annnotations
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 49-52 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
| T2 | 403-406 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
| T3 | 734-737 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 74-77 | Disease | denotes | CHF | http://purl.obolibrary.org/obo/MONDO_0005009 |
| T2 | 723-726 | Disease | denotes | CHF | http://purl.obolibrary.org/obo/MONDO_0005009 |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 49-52 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
| T2 | 49-52 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
| T3 | 403-406 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
| T4 | 403-406 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
| T5 | 734-737 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
| T6 | 734-737 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 49-52 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK |
| T3 | 403-406 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK |
| T5 | 734-737 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 74-77 | Phenotype | denotes | CHF | HP:0001635 |
| T2 | 723-726 | Phenotype | denotes | CHF | HP:0001635 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 49-52 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
| T2 | 403-406 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
| T3 | 734-737 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-114 | Sentence | denotes | Synthesis and biological activity of ganglioside GM3 analogues with a (S)-CHF-Sialoside linkage and an alkyne tag. |
| T2 | 115-343 | Sentence | denotes | The alkyne tag, consisting of only two carbons, is widely used as a bioorthogonal functional group due to its compactness and nonpolar structure, and various probes consisting of lipids bearing an alkyne tag have been developed. |
| T3 | 344-524 | Sentence | denotes | Here, we designed and synthesized analogues of ganglioside GM3 bearing an alkyne tag in the fatty acid moiety and evaluated the effect of the alkyne tag on the biological activity. |
| T4 | 525-771 | Sentence | denotes | To eliminate the influence of other factors such as degradation of the glycan chain when evaluating biological activity in a cellular environment, we introduced the tag into sialidase-resistant (S)-CHF-linked GM3 analogues developed by our group. |
| T5 | 772-891 | Sentence | denotes | The designed analogues were efficiently synthesized by tuning the protecting group of the glucosylsphingosine acceptor. |
| T6 | 892-1025 | Sentence | denotes | The growth-promoting effect of these analogues on Had-1 cells was dramatically altered depending upon the position of the alkyne tag. |